{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29147012", "DateCompleted": {"Year": "2018", "Month": "07", "Day": "03"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "11", "Day": "17"}], "Language": ["eng"], "ELocationID": ["10.1038/emm.2017.156"], "Journal": {"ISSN": "2092-6413", "JournalIssue": {"Volume": "49", "Issue": "11", "PubDate": {"Year": "2017", "Month": "Nov", "Day": "17"}}, "Title": "Experimental & molecular medicine", "ISOAbbreviation": "Exp Mol Med"}, "ArticleTitle": "Piperidylmethyloxychalcone improves immune-mediated acute liver failure via inhibiting TAK1 activity.", "Pagination": {"StartPage": "e392", "MedlinePgn": "e392"}, "Abstract": {"AbstractText": ["Mice deficient in the toll-like receptor (TLR) or the myeloid differentiation factor 88 (MyD88) are resistant to acute liver failure (ALF) with sudden death of hepatocytes. Chalcone derivatives from medicinal plants protect from hepatic damages including ALF, but their mechanisms remain to be clarified. Here, we focused on molecular basis of piperidylmethyloxychalcone (PMOC) in the treatment of TLR/MyD88-associated ALF. C57BL/6J mice were sensitized with D-galactosamine (GalN) and challenged with Escherichia coli lipopolysaccharide (LPS, TLR4 agonist) or oligodeoxynucleotide containing unmethylated CpG motif (CpG ODN, TLR9 agonist) for induction of ALF. Post treatment with PMOC sequentially ameliorated hepatic inflammation, apoptosis of hepatocytes, severe liver injury and shock-mediated death in ALF-induced mice. As a mechanism, PMOC inhibited the catalytic activity of TGF-\u03b2-activated kinase 1 (TAK1) in a competitive manner with respect to ATP, displaced fluorescent ATP probe from the complex with TAK1, and docked at the ATP-binding active site on the crystal structure of TAK1. Moreover, PMOC inhibited TAK1 auto-phosphorylation, which is an axis in the activating pathways of nuclear factor-\u03baB (NF-\u03baB) or activating protein 1 (AP1), in the liver with ALF in vivo or in primary liver cells stimulated with TLR agonists in vitro. PMOC consequently suppressed TAK1-inducible NF-\u03baB or AP1 activity in the inflammatory injury, an early pathogenesis leading to ALF. The results suggested that PMOC could contribute to the treatment of TLR/MyD88-associated ALF with the ATP-binding site of TAK1 as a potential therapeutic target."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Chungbuk National University, Cheongju, Korea."}], "LastName": "Park", "ForeName": "Sun Hong", "Initials": "SH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Chungbuk National University, Cheongju, Korea."}], "LastName": "Kwak", "ForeName": "Jeong-Ah", "Initials": "JA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Chungnam National University, Daejeon, Korea."}], "LastName": "Jung", "ForeName": "Sang-Hun", "Initials": "SH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Veterinary Medicine, Chungbuk National University, Cheongju, Korea."}], "LastName": "Ahn", "ForeName": "Byeongwoo", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Chonnam National University, Kwangju, Korea."}], "LastName": "Cho", "ForeName": "Won-Jea", "Initials": "WJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Chungbuk National University, Cheongju, Korea."}], "LastName": "Yun", "ForeName": "Cheong-Yong", "Initials": "CY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Chungbuk National University, Cheongju, Korea."}], "LastName": "Na", "ForeName": "Chang Seon", "Initials": "CS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Chungbuk National University, Cheongju, Korea."}], "LastName": "Hwang", "ForeName": "Bang Yeon", "Initials": "BY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Chungbuk National University, Cheongju, Korea."}], "LastName": "Hong", "ForeName": "Jin Tae", "Initials": "JT"}, {"Identifier": ["0000-0001-6656-6523"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Chungbuk National University, Cheongju, Korea."}], "LastName": "Han", "ForeName": "Sang-Bae", "Initials": "SB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Chungbuk National University, Cheongju, Korea."}], "LastName": "Kim", "ForeName": "Youngsoo", "Initials": "Y"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Exp Mol Med", "NlmUniqueID": "9607880", "ISSNLinking": "1226-3613"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "Protective Agents"}, {"RegistryNumber": "5S5A2Q39HX", "NameOfSubstance": "Chalcone"}, {"RegistryNumber": "EC 2.7.11.25", "NameOfSubstance": "MAP Kinase Kinase Kinases"}, {"RegistryNumber": "EC 2.7.11.25", "NameOfSubstance": "MAP kinase kinase kinase 7"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["analogs & derivatives", "chemistry", "pharmacology"], "DescriptorName": "Chalcone"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation"}, {"QualifierName": ["drug effects", "immunology", "metabolism", "pathology"], "DescriptorName": "Hepatocytes"}, {"QualifierName": ["complications"], "DescriptorName": "Immune System Diseases"}, {"QualifierName": ["drug therapy", "etiology", "metabolism", "pathology"], "DescriptorName": "Liver Failure, Acute"}, {"QualifierName": ["antagonists & inhibitors", "chemistry", "metabolism"], "DescriptorName": "MAP Kinase Kinase Kinases"}, {"QualifierName": ["drug effects", "immunology", "metabolism", "pathology"], "DescriptorName": "Macrophages"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Models, Molecular"}, {"QualifierName": [], "DescriptorName": "Molecular Conformation"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": [], "DescriptorName": "Phosphorylation"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Protective Agents"}, {"QualifierName": [], "DescriptorName": "Protein Binding"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Chen Y, Sun R. Toll-like receptors in acute liver injury and regeneration. Int Immunopharmacol 2011; 11: 1433\u20131441.", "ArticleIdList": ["21601014"]}, {"Citation": "Heymann F, Tacke F. Immunology in the liver\u2014from homeostasis to disease. Nat Rev Gastroenterol Hepatol 2016; 13: 88\u2013110.", "ArticleIdList": ["26758786"]}, {"Citation": "Klett J, Reeves J, Oberhauser N, Perez-Regidor L, Martin-Santamaria S. Modulation of Toll-like receptor 4: insights from X-ray crystallography and molecular modeling. Curr Top Med Chem 2014; 14: 2672\u20132683.", "ArticleIdList": ["25515751"]}, {"Citation": "Bauer S. Toll-like receptor 9 processing: the key event in Toll-like receptor 9 activation? Immunol Lett 2013; 149: 85\u201387.", "ArticleIdList": ["23183093"]}, {"Citation": "Bryant CE, Symmons M, Gay NJ. Toll-like receptor signalling through macromolecular protein complexes. Mol Immunol 2015; 63: 162\u2013165.", "ArticleIdList": ["25081091"]}, {"Citation": "Warner N, Nunez G. MyD88: a critical adaptor protein in innate immunity signal transduction. J Immunol 2013; 190: 3\u20134.", "ArticleIdList": ["23264668"]}, {"Citation": "Ve T, Gay NJ, Mansell A, Kobe B, Kellie S. Adaptors in toll-like receptor signaling and their potential as therapeutic targets. Curr Drug Targets 2012; 13: 1360\u20131374.", "ArticleIdList": ["22664090"]}, {"Citation": "Ajibade AA, Wang HY, Wang RF. Cell type-specific function of TAK1 in innate immune signaling. Trends Immunol 2013; 34: 307\u2013316.", "ArticleIdList": ["23664135"]}, {"Citation": "Napetschnig J, Wu H. Molecular basis of NF-\u03baB signaling. Annu Rev Biophys 2013; 42: 443\u2013468.", "ArticleIdList": ["PMC3678348", "23495970"]}, {"Citation": "Ikushima H, Negishi H, Taniguchi T. The IRF family transcription factors at the interface of innate and adaptive immune responses. Cold Spring Harb Symp Quant Biol 2013; 78: 105\u2013116.", "ArticleIdList": ["24092468"]}, {"Citation": "Maes M, Vinken M, Jaeschke H. Experimental models of hepatotoxicity related to acute liver failure. Toxicol Appl Pharmacol 2016; 290: 86\u201397.", "ArticleIdList": ["PMC4691574", "26631581"]}, {"Citation": "Yi AK, Yoon H, Park JE, Kim BS, Kim HJ, Martinez-Hernandez A. CpG DNA-mediated induction of acute liver injury in D-galactosamine-sensitized mice: the mitochondrial apoptotic pathway-dependent death of hepatocytes. J Biol Chem 2006; 281: 15001\u201315012.", "ArticleIdList": ["16554296"]}, {"Citation": "Decker K, Keppler D. Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev Physiol Biochem Pharmacol 1974; 71: 77\u2013106.", "ArticleIdList": ["4375846"]}, {"Citation": "Tsutsui H, Nishiguchi S. Importance of Kupffer cells in the development of acute liver injuries in mice. Int J Mol Sci 2014; 15: 7711\u20137730.", "ArticleIdList": ["PMC4057701", "24802875"]}, {"Citation": "Tacke F, Luedde T, Trautwein C. Inflammatory pathways in liver homeostasis and liver injury. Clin Rev Allergy Immunol 2009; 36: 4\u201312.", "ArticleIdList": ["18600481"]}, {"Citation": "Bantel H, Schulze-Osthoff K. Mechanisms of cell death in acute liver failure. Front Physiol 2012; 3: 79.", "ArticleIdList": ["PMC3317271", "22485095"]}, {"Citation": "Rutherford A, Chung RT. Acute liver failure: mechanisms of hepatocyte injury and regeneration. Semin Liver Dis 2008; 28: 167\u2013174.", "ArticleIdList": ["18452116"]}, {"Citation": "Dorman RB, Gujral JS, Bajt ML, Farhood A, Jaeschke H. Generation and functional significance of CXC chemokines for neutrophil-induced liver injury during endotoxemia. Am J Physiol Gastrointest Liver Physiol 2005; 288: G880\u2013G886.", "ArticleIdList": ["15576625"]}, {"Citation": "Guan LP, Nan JX, Jin XJ, Jin QH, Kwak KC, Chai KY et al. Protective effects of chalcone derivatives for acute liver injury in mice. Arch Pharm Res 2005; 28: 81\u201386.", "ArticleIdList": ["15742813"]}, {"Citation": "Zhao Z, Park SM, Guan L, Wu Y, Lee JR, Kim SC et al. Isoliquiritigenin attenuates oxidative hepatic damage induced by carbon tetrachloride with or without buthionine sulfoximine. Chem Biol Interact 2015; 225: 13\u201320.", "ArticleIdList": ["25450236"]}, {"Citation": "Dorn C, Massinger S, Wuzik A, Heilmann J, Hellerbrand C. Xanthohumol suppresses inflammatory response to warm ischemia-reperfusion induced liver injury. Exp Mol Pathol 2013; 94: 10\u201316.", "ArticleIdList": ["22634733"]}, {"Citation": "Yang M, Li N, Li F, Zhu Q, Liu X, Han Q et al. Xanthohumol, a main prenylated chalcone from hops, reduces liver damage and modulates oxidative reaction and apoptosis in hepatitis C virus infected Tupaia belangeri. Int Immunopharmacol 2013; 16: 466\u2013474.", "ArticleIdList": ["23669332"]}, {"Citation": "Baer M, Dillner A, Schwartz RC, Sedon C, Nedospasov S, Johnson PF. Tumor necrosis factor \u03b1 transcription in macrophages is attenuated by an autocrine factor that preferentially induces NF-\u03baB p50. Mol Cell Biol 1998; 18: 5678\u20135689.", "ArticleIdList": ["PMC109154", "9742085"]}, {"Citation": "Hawn TR, Ozinsky A, Underhill DM, Buckner FS, Akira S, Aderem A. Leishmania major activates IL-1\u03b1 expression in macrophages through a MyD88-dependent pathway. Microbes Infect 2002; 4: 763\u2013771.", "ArticleIdList": ["12270723"]}, {"Citation": "Moon KY, Hahn BS, Lee J, Kim YS. A cell-based assay system for monitoring NF-\u03baB activity in human HaCat transfectant cells. Anal Biochem 2001; 292: 17\u201321.", "ArticleIdList": ["11319812"]}, {"Citation": "Loguercio C, Festi D. Silybin and the liver: from basic research to clinical practice. World J Gastroenterol 2011; 17: 2288\u20132301.", "ArticleIdList": ["PMC3098397", "21633595"]}, {"Citation": "Marra F, Tacke F. Roles for chemokines in liver disease. Gastroenterology 2014; 147: 577\u2013594 e1.", "ArticleIdList": ["25066692"]}, {"Citation": "Buss H, Dorrie A, Schmitz ML, Hoffmann E, Resch K, Kracht M. Constitutive and interleukin-1-inducible phosphorylation of p65 NF-\u03baB at serine 536 is mediated by multiple protein kinases including I\u03baB kinase (IKK)-\u03b1, IKK\u03b2, IKK\u03b5, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription. J Biol Chem 2004; 279: 55633\u201355643.", "ArticleIdList": ["15489227"]}, {"Citation": "Chen W, Srinath H, Lam SS, Schiffer CA, Royer WE Jr, Lin K. Contribution of Ser386 and Ser396 to activation of interferon regulatory factor 3. J Mol Biol 2008; 379: 251\u2013260.", "ArticleIdList": ["PMC2410038", "18440553"]}, {"Citation": "Park SH, Baek SI, Yun J, Lee S, Yoon da Y, Jung JK et al. IRAK4 as a molecular target in the amelioration of innate immunity-related endotoxic shock and acute liver injury by chlorogenic acid. J Immunol 2015; 194: 1122\u20131130.", "ArticleIdList": ["25548221"]}, {"Citation": "Ninomiya-Tsuji J, Kajino T, Ono K, Ohtomo T, Matsumoto M, Shiina M et al. A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase. J Biol Chem 2003; 278: 18485\u201318490.", "ArticleIdList": ["12624112"]}, {"Citation": "Brown K, Vial SC, Dedi N, Long JM, Dunster NJ, Cheetham GM. Structural basis for the interaction of TAK1 kinase with its activating protein TAB1. J Mol Biol 2005; 354: 1013\u20131020.", "ArticleIdList": ["16289117"]}, {"Citation": "Ben Ari Z, Avlas O, Pappo O, Zilbermints V, Cheporko Y, Bachmetov L et al. Reduced hepatic injury in Toll-like receptor 4-deficient mice following D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure. Cell Physiol Biochem 2012; 29: 41\u201350.", "ArticleIdList": ["22415073"]}, {"Citation": "Shah N, Montes de Oca M, Jover-Cobos M, Tanamoto K, Muroi M, Sugiyama K et al. Role of Toll-like receptor 4 in mediating multiorgan dysfunction in mice with acetaminophen induced acute liver failure. Liver Transpl 2013; 19: 751\u2013761.", "ArticleIdList": ["23554142"]}, {"Citation": "Uchida Y, Ke B, Freitas MC, Yagita H, Akiba H, Busuttil RW et al. T-cell immunoglobulin mucin-3 determines severity of liver ischemia/reperfusion injury in mice in a TLR4-dependent manner. Gastroenterology 2010; 139: 2195\u20132206.", "ArticleIdList": ["PMC2970711", "20637206"]}, {"Citation": "Hritz I, Velayudham A, Dolganiuc A, Kodys K, Mandrekar P, Kurt-Jones E et al. Bone marrow-derived immune cells mediate sensitization to liver injury in a myeloid differentiation factor 88-dependent fashion. Hepatology 2008; 48: 1342\u20131347.", "ArticleIdList": ["PMC7043384", "18798338"]}, {"Citation": "Marques PE, Amaral SS, Pires DA, Nogueira LL, Soriani FM, Lima BH et al. Chemokines and mitochondrial products activate neutrophils to amplify organ injury during mouse acute liver failure. Hepatology 2012; 56: 1971\u20131982.", "ArticleIdList": ["22532075"]}, {"Citation": "Jiang W, Sun R, Zhou R, Wei H, Tian Z. TLR-9 activation aggravates concanavalin A-induced hepatitis via promoting accumulation and activation of liver CD4+ NKT cells. J Immunol 2009; 182: 3768\u20133774.", "ArticleIdList": ["19265155"]}, {"Citation": "Imamura M, Tsutsui H, Yasuda K, Uchiyama R, Yumikura-Futatsugi S, Mitani K et al. Contribution of TIR domain-containing adapter inducing IFN-\u03b2-mediated IL-18 release to LPS-induced liver injury in mice. J Hepatol 2009; 51: 333\u2013341.", "ArticleIdList": ["19501931"]}, {"Citation": "Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007; 317: 121\u2013124.", "ArticleIdList": ["17615358"]}, {"Citation": "Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA et al. TLR4 enhances TGF-\u03b2 signaling and hepatic fibrosis. Nat Med 2007; 13: 1324\u20131332.", "ArticleIdList": ["17952090"]}, {"Citation": "Adachi K, Tsutsui H, Kashiwamura S, Seki E, Nakano H, Takeuchi O et al. Plasmodium berghei infection in mice induces liver injury by an IL-12- and toll-like receptor/myeloid differentiation factor 88-dependent mechanism. J Immunol 2001; 167: 5928\u20135934.", "ArticleIdList": ["11698470"]}, {"Citation": "Wu J, Powell F, Larsen NA, Lai Z, Byth KF, Read J et al. Mechanism and in vitro pharmacology of TAK1 inhibition by (5Z-7-Oxozeaenol. ACS Chem Biol 2013; 8: 643\u2013650.", "ArticleIdList": ["23272696"]}, {"Citation": "Du H, Matsushima T, Spyvee M, Goto M, Shirota H, Gusovsky F et al. Discovery of a potent, metabolically stabilized resorcylic lactone as an anti-inflammatory lead. Bioorg Med Chem Lett 2009; 19: 6196\u20136199.", "ArticleIdList": ["19783437"]}]}], "History": [{"Year": "2016", "Month": "12", "Day": "1"}, {"Year": "2017", "Month": "3", "Day": "27"}, {"Year": "2017", "Month": "4", "Day": "17"}, {"Year": "2017", "Month": "11", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "11", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "7", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "11", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["29147012", "PMC5704185", "10.1038/emm.2017.156", "emm2017156"]}}]}